Drug-gene testing, also called pharmacogenomics or pharmacogenetics, is the study of how your genes affect your body's response to medications. Pharmacogenomic tests look for changes or variants in these genes that may determine whether a medication could be an effective treatment for you or whether you could have side effects to a specific medication/


  • Improved patient outcomes when initiating drug regimens
  • Reduced risk of harmful drug-to-drug interactions
  • Reduced risk of Adverse Drug Events

In recent years pharmacogenomics testing (PGx) as a routine clinical tool in patient care has become more commonplace. Advances in technology have made testing more accurate, quicker to implement in a clinical laboratory setting and less costly. These factors, combined with great strides in our interpretation of genetic data have led to a revolutionary way in how physicians approach patient care and the effectiveness of medication therapy.

Recent studies have shown that PGx testing can improve clinical outcomes while simultaneously decreasing healthcare costs. Reduction in lengthy trial-and-error periods during the selection of a new pharmacotherapy, along with treatment intervention for Adverse Drug Events and serious drug interactions, have not only emerged to improve patient care, but also to reduce costs in the clinic.